VR09 Cell Line: An EBV-Positive Lymphoblastoid Cell Line with In Vivo Characteristics of Diffuse Large B Cell Lymphoma of Activated B-Cell Type
Figure 3
A) Spherical subcutaneous mass (arrow) in Rag-2−/− γ-chain−/− mice 36 days after VR09 cell line injection (representative case). (B) Timing of tumor development in vivo (6 mice s.c. injected with 5×106 cells/mouse).